<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref18">
 <label>18.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Hirakawa</surname>  
    <given-names>M</given-names>
   </string-name>, 
   <string-name>
    <surname>Sato</surname>  
    <given-names>Y</given-names>
   </string-name>, 
   <string-name>
    <surname>Ohnuma</surname>  
    <given-names>H</given-names>
   </string-name>, 
   <etal>et al.</etal>
  </person-group>  
  <article-title>A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker</article-title>. 
  <source>Cancer Chemother Pharmacol</source>  
  <year>2013</year>;
  <volume>71</volume>:
  <fpage>789</fpage>–
  <lpage>97</lpage>.
  <pub-id pub-id-type="pmid">23338051</pub-id>
 </mixed-citation>
</ref>
